Reporting specific airway resistance (sRaw) in children: mean or median? Source: Annual Congress 2006 - Landmark developments in lung function testing: 2006 Year: 2006
Pseudomonas aeruginosa (Pa) antibiotic resistance (AR): Comparison in adults and children with cystic fibrosis (CF)Source: Annual Congress 2010 - Cystic fibrosis: lung disease infection and more Year: 2010
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Dual release ciprofloxacin for inhalation (DRCFI) reduces sputum pseudomonas aeruginosa (Pa ) density and delays time to infective pulmonary exacerbation in non-cystic fibrosis (CF) bronchiectasis (BE) Source: Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis Year: 2011
Evaluation of the pulmonary function of patients with cystic fibrosis aged 3-18 year old by using impulse oscillometry and spirometry Source: International Congress 2015 – Cystic fibrosis: microbiology, immunology and assessment Year: 2015
Lung clearance index (LCI) and hyperinflation in children with cystic fibrosis (CF) Source: Annual Congress 2012 - Cystic fibrosis (adults and children): new basic and clinical physiology research Year: 2012
Late Breaking Abstract - Reduction in frequency of pulmonary exacerbations (PE) with inhaled ARD-3150 in non-cystic fibrosis bronchiectasis (NCFB) patients is independent of Pseudomonas aeruginosa (PA) susceptibility at baseline Source: International Congress 2017 – Update on community acquired pneumonia Year: 2017
Arterial partial pressure of oxygen (PaO2) - a marker for cystic fibrosis (CF) lung disease and chronic airway infection Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019
ABPA syndrome (ABPAs) in CF: FEV1 decline, infectious exacerbations and BMI before and after the year of diagnosis (index year), a case control study Source: International Congress 2014 – Cystic fibrosis: basic science, physiology and clinical aspects Year: 2014
Scond may better discriminate severe therapy resistant asthma (STRA) from mild-moderate asthma than lung clearance index (LCI) Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016
Breathing pattern during rest and exercise in patients with cystic fibrosis (CF), pulmonary fibrosis (PF) and COPD before lung transplantation Source: Eur Respir J 2005; 26: Suppl. 49, 685s Year: 2005
Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015
Lung clearance index (LCI) at age 1-4 years vs lung function and chest X-ray (CXR) scores at age 7 years in children with CF Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Is lung function diminished by 3 months of age in infants with cystic fibrosis (CF) diagnosed by newborn screening (NBS)? Source: Annual Congress 2010 - Functional assessment of paediatric lung disease Year: 2010
Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017
Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001
Lung function abnormalities in asthmatic children (a 3-5 year follow-up study) Source: Eur Respir J 2001; 18: Suppl. 33, 120s Year: 2001
Degree of bronchial hyperresponsiveness (BHR) and new onset of respiratory diseases 9 years later Source: Annual Congress 2011 - Asthma mechanisms Year: 2011
Variability of the lung clearance index (LCI) assessed pre and post physiotherapy in patients with cystic fibrosis (CF) Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology Year: 2008
Changes in lung function and comorbidity in patients with COPD over 4 to 10 years of follow-up Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013